Jiangsu Hengrui Medicine Co Ltd (600276) — Cash Flow Quality Index
Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow Quality Index of 3.70x as of September 2025. Operating cash flow of CN¥4.81 Billion exceeds net income of CN¥1.30 Billion, indicating high earnings quality where cash backs reported profits. Explore Jiangsu Hengrui Medicine Co Ltd (600276) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Hengrui Medicine Co Ltd Cash Flow Quality Index (1999–2024)
Historical Cash Flow Quality Index for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jiangsu Hengrui Medicine Co Ltd (600276) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year earnings quality comparison for Jiangsu Hengrui Medicine Co Ltd. For live market cap and the full company financial profile, see 600276 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥7.42 Billion | CN¥6.34 Billion | ▼ -34.4% |
| 2023 | 1.79x | CN¥7.64 Billion | CN¥4.28 Billion | ▲ +438.8% |
| 2022 | 0.33x | CN¥1.27 Billion | CN¥3.82 Billion | ▼ -64.8% |
| 2021 | 0.94x | CN¥4.22 Billion | CN¥4.48 Billion | ▲ +73.0% |
| 2020 | 0.54x | CN¥3.43 Billion | CN¥6.31 Billion | ▼ -24.1% |
| 2019 | 0.72x | CN¥3.82 Billion | CN¥5.33 Billion | ▲ +4.9% |
| 2018 | 0.68x | CN¥2.77 Billion | CN¥4.06 Billion | ▼ -11.7% |
| 2017 | 0.77x | CN¥2.55 Billion | CN¥3.29 Billion | ▼ -21.4% |
| 2016 | 0.98x | CN¥2.59 Billion | CN¥2.63 Billion | ▼ -3.9% |
| 2015 | 1.02x | CN¥2.28 Billion | CN¥2.22 Billion | ▲ +2.3% |
| 2014 | 1.00x | CN¥1.57 Billion | CN¥1.57 Billion | ▼ -5.3% |
| 2013 | 1.06x | CN¥1.36 Billion | CN¥1.29 Billion | ▲ +26.9% |
| 2012 | 0.83x | CN¥958.37 Million | CN¥1.15 Billion | ▲ +48.4% |
| 2011 | 0.56x | CN¥527.36 Million | CN¥940.41 Million | ▲ +9.8% |
| 2010 | 0.51x | CN¥385.95 Million | CN¥755.44 Million | ▼ -19.3% |
| 2009 | 0.63x | CN¥439.12 Million | CN¥693.30 Million | ▲ +134.9% |
| 2008 | 0.27x | CN¥117.46 Million | CN¥435.59 Million | ▼ -48.4% |
| 2007 | 0.52x | CN¥218.87 Million | CN¥418.53 Million | ▼ -59.7% |
| 2006 | 1.30x | CN¥266.18 Million | CN¥204.90 Million | ▼ -8.7% |
| 2005 | 1.42x | CN¥227.88 Million | CN¥160.07 Million | ▼ -17.5% |
| 2004 | 1.73x | CN¥209.41 Million | CN¥121.32 Million | ▲ +16.3% |
| 2003 | 1.48x | CN¥136.82 Million | CN¥92.20 Million | ▲ +136.0% |
| 2002 | 0.63x | CN¥49.84 Million | CN¥79.27 Million | ▲ +345.5% |
| 2001 | 0.14x | CN¥11.49 Million | CN¥81.40 Million | ▼ -52.8% |
| 2000 | 0.30x | CN¥19.61 Million | CN¥65.54 Million | ▼ -54.4% |
| 1999 | 0.66x | CN¥33.89 Million | CN¥51.65 Million | — |